Sintx Technologies announces U.S. patent notice of allowance

SINTX Technologies (SINT) announced that the United States Patent and Trademark Office issued a Notice of Allowance for a patent application containing method claims covering the Company’s antipathogenic fabric technology. This development builds upon SINTX’s previously announced patent allowance for its Antipathogenic Fibrous Materials composition patent, expanding the Company’s Intellectual Property to protect both the material itself and the processes that bring it to market. This dual coverage strengthens the Company’s competitive advantage, enhances licensing and partnership opportunities, and broadens potential applications across medical textiles, filtration media, and other infection-prone surfaces. These two patent families create a comprehensive IP competitive barrier around SINTX’s surface-level pathogen-inactivation technology, covering applications in wound dressings, surgical drapes and gowns, filtration media, personal protective equipment, and high-touch clinical surfaces.